Chicago, IL (PRWEB) January 17, 2014
The birth control safety advocates at DrugNews.net have added updated information for women who took the contraceptives Yaz or Yasmin. New court records this month show lawsuits alleging side effects from the drug have dropped slightly as thousands have received settlements*.
The DrugNews Center is a free resource for those taking popular prescription drugs, providing the latest safety alerts, recalls, studies and legal news. Patients can avoid potential dangers, see if others are experiencing similar side effects and decide if they need legal advice.
The resource center has added health warnings for Yaz and Yasmin from experts such as the British Medical Journal** and FDA*** that birth control pills containing the hormone drospirenone can increase the risk of blood clots.
A number of women have already filed a Yaz lawsuit alleging side effects, leading cases to be consolidated in a special federal Multi-District Litigation court. (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).
DrugNews has also added information showing Bayer, the maker of Yaz, has already spent around $1.575 billion to settle approximately 7,660 Yaz lawsuits alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT)****.
Now, the resource center has compiled the latest court records this month, which show the number of pending Yaz claims has dropped from 9,826 on December 16th to 9,781 as of January 15th*.
Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugNews Center or speak with a lawyer about their options under the current settlement.
Due to the complexity of drug injury cases, DrugNews only recommends lawyers who have already settled Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*JPML 1/15/14; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-January-15-2014.pdf
**BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
***FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
****Bayer Stockholder’s Newsletter, Explanatory Notes; Legal Risks, 10/31/13; stockholders-newsletter-q3-2013.bayer.com/en/explanatory-notes.aspx